About Klox Technologies Inc.
Klox Technologies Inc. is a private regenerative medicine company, advancing the development of its FLE platform, also known as Fluorescence Biomodulation, for specific skin/soft tissue conditions and diseases. We believe in providing healthcare professionals with novel and effective treatment solutions, which in turn allow patients to experience positive results without extensive side effects or high costs associated with existing stand of care treatments.
What is our corporate mission?
Klox strives to expand the benefits of its proprietary FLE platform by identify treatment ‘gaps’ or unmet needs for inflammatory diseases and conditions affecting the skin and soft tissues. Klox aspires to deliver superior efficacy for patients compared to standard of care, while ultimately being cost effective, but most importantly retaining a clean safety profile.